Premium
Baird‐Parker Medium Supplemented with Acriflavine, Polymyxins and Sulphonamide for the Selective Isolation of Staphylococcus aureus from Heavily Contaminated Materials
Author(s) -
DEVRIESE L. A.
Publication year - 1981
Publication title -
journal of applied bacteriology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.889
H-Index - 156
eISSN - 1365-2672
pISSN - 0021-8847
DOI - 10.1111/j.1365-2672.1981.tb00899.x
Subject(s) - acriflavine , staphylococcus aureus , polymyxin , isolation (microbiology) , microbiology and biotechnology , chemistry , bacitracin , polymyxin b , antibiotics , biology , bacteria , genetics
Acriflavine was found to be less inhibitory to Staphylococcus aureus than to other staphylococci. Advantage was taken of this selective effect and of the synergistic action of polymyxins and sulphonamides on Proteus strains to improve the selective capacity of Baird‐Parker's Staph. aureus isolation medium. A supplement mixture containing acriflavine, sodium sulphamezathine and low levels of polymyxin in addition to the usual egg yolk and potassium tellurite is proposed for use with this medium.